From the Cepheid website:
“Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. The test leverages the design principles of our current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic /c coronavirus SARS-CoV-2 in as soon as 30 minutes for positive results* with less than a minute of hands on time to prepare the sample.
Xpert® Xpress SARS-CoV-2 can be utilized in multiple settings where actionable test results are needed to make informed treatment decisions quickly. The test delivers point-of-care results with the same level of performance seen in reference labs. The test is designed for use on Cepheid’s GeneXpert® Systems, which have a worldwide footprint of more than 23,000 placements.”
The SARS-CoV-2 cartridge has a resources webpage within the main Cepheid website.
Cepheid GeneXpert Sars-CoV-2 datasheet (overview of cartridge information).
Cepheid have produced a factsheet for healthcare workers, including Health and safety.
The above fact sheet directs healthcare workers to the CDC interim laboratory biosafety guidelines regarding the use of PPE when collecting samples for use with the GeneXpert.
They suggest also referring to the CDC interim guidelines for collecting, handling, and testing clinical specimens for COVID-19.
Running the test (hub configuration) | Running the test (tablet configuration) | Cepheid GeneXpert Sars-CoV-2 validation protocol